ArticleCancer medicine2018

Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.

Shu-Qi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.